GTBP
GT Biopharma Inc
Price:  
2.17 
USD
Volume:  
4,953.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GTBP Intrinsic Value

-1,220.23 %
Upside

What is the intrinsic value of GTBP?

As of 2025-04-22, the Intrinsic Value of GT Biopharma Inc (GTBP) is -24.31 USD. This GTBP valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.17 USD, the upside of GT Biopharma Inc is -1,220.23%.

Is GTBP undervalued or overvalued?

Based on its market price of 2.17 USD and our intrinsic valuation, GT Biopharma Inc (GTBP) is overvalued by 1,220.23%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

2.17 USD
Stock Price
-24.31 USD
Intrinsic Value
Intrinsic Value Details

GTBP Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -24.31 - -24.31 -24.31 -1,220.23%
P/E (132.05) - (231.71) (160.68) -7504.7%
DDM - Stable (35.68) - (108.51) (72.09) -3422.3%
DDM - Multi (31.99) - (78.75) (45.86) -2213.4%

GTBP Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 5.51
Beta 0.77
Outstanding shares (mil) 2.54
Enterprise Value (mil) 1.56
Market risk premium 4.60%
Cost of Equity 10.79%
Cost of Debt 5.00%
WACC 7.23%